PlainRecalls
FDA Drug Critical Class I Ongoing

UMOVY ACIDO HIALURONICO, Conenido: 30 capletas de 850mg, distribuido por: EREN NATURAL S.A. DE C.V, Zappan, Jal. C.P, UPC 7503046054134

Reported: June 25, 2025 Initiated: May 21, 2025 #D-0493-2025

Product Description

UMOVY ACIDO HIALURONICO, Conenido: 30 capletas de 850mg, distribuido por: EREN NATURAL S.A. DE C.V, Zappan, Jal. C.P, UPC 7503046054134

Reason for Recall

Marketed without approved NDA/ANDA- Laboratory analysis found product to be tainted with undeclared ingredients: Dexamethasone and Diclofenac.

Details

Recalling Firm
Umary-USA.com
Units Affected
1,704 30-count bottles
Distribution
U.S. Nationwide via internet.
Location
Nogales, AZ

Frequently Asked Questions

What product was recalled?
UMOVY ACIDO HIALURONICO, Conenido: 30 capletas de 850mg, distribuido por: EREN NATURAL S.A. DE C.V, Zappan, Jal. C.P, UPC 7503046054134. Recalled by Umary-USA.com. Units affected: 1,704 30-count bottles.
Why was this product recalled?
Marketed without approved NDA/ANDA- Laboratory analysis found product to be tainted with undeclared ingredients: Dexamethasone and Diclofenac.
Which agency issued this recall?
This recall was issued by the FDA Drug on June 25, 2025. Severity: Critical. Recall number: D-0493-2025.